Other considerations include the limited number of C282Y or H63D homozygotes, possible HFE gene disequilibrium with other measured covariates and limited information on clinical diagnosis of hemochromatosis, and markers of inflammation (MCP-1) or iron metabolism (serum ferritin and transferrin saturation levels). The gene discussed is CCL2; the disease is hemochromatosis type 1.